Press releases

16
May 2013
20:30 E.S.T.

TAL-effector nuclease: Issuance by the USPTO of Two New Patents – Cellectis provides its customers TALEN™ product under license of these patents to easily achieve any genome engineering projects.

Read more
2
May 2013
20:30 E.S.T.

David Sourdive, Vice President of Corporate Development at Cellectis, has been appointed by French Foreign Trade Minister Nicole Bricq to boost France’s export performance in the health sector

Read more
29
Apr 2013
20:30 E.S.T.

Cellectis: 2012 financial results

Read more
17
Apr 2013
20:30 E.S.T.

Cellectis bioresearch launches VizuCELL cell lines for live cell imaging

Read more
8
Apr 2013
20:30 E.S.T.

Launching of CanCELL™ cell lines, featuring knock-out of the major cancer relevant oncogenes and tumor suppressor genes

Read more
7
Mar 2013
21:30 E.S.T.

Cellectis and Stemgent Partner to Provide Custom Genome-engineered iPS Cells

Read more
25
Feb 2013
21:30 E.S.T.

Cellectis announces appointment of Pierre Schwich as Group CFO

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US